Clinical Data, Articles, and Studies

Lip rejuvenation and plumping using an Nd:YAG 1064nm laser with a 650-microsecond pulse duration can provide significant improvement without the use of needles and with a high degree of patient satisfaction, minimal discomfort, no adverse effects and strong interest in ongoing treatments among those treated.

The efficacy of this laser on this uniquely broad range of conditions, aside from the underlying versatility of the 1064nm wavelength, is related to its ability to produce a very wide range of fluences at the 650-microsecond pulse duration, which in turn enables the clinician to treat areas with multiple passes or pulses of the laser even on tanned or darker skin tones, for maximum tissue response.

The implications to this are that laser plays an integral role in eliminating nail fungus by damaging the susceptible representations of the organism.

While melasma affects people of all skin types, it is predominant in women with darker skin (Fitzpatrick III-VI), which can add further difficulty to an already hard-to-treat, chronic disorder.

Laser and light-based treatments for acne have a long history of use and address the desire for interventions that can overcome the problems of poor patient compliance with topical therapies and side effects accompanying systemic medications.

Participants had acute lumbago, which occurred within 1 to 7 days before treatment. 28 patients were exposed to laser treatment, whereas 22 were enrolled as a control group.

This study was conducted to evaluate the safety and clinical efficacy of a novel short pulsed, 650 microsecond pulsed 1064nm NdYag laser for the treatment of lower extremity telangiectasias.

This study was conducted to evaluate the safety and clinical efficacy of a 650-microsecond Short Pulsed Nd:YAG 1064nm Laser for treatment of Infantile Hemangiomas.

This 650-microsecond laser effectively and safely treats both pediatric and adult acne patients, regardless of skin type. It penetrates deeper than any other laser/light modality, allowing energy to reach sebaceous glands where it will achieve bacterial destruction.

In the last three years we enrolled 30 patients, from 25 to 60 years old, with chronic induration penis plastica.

In 2015, 10 patients with incomplete TCNSI, occurred at least one year before laser treatment and documented by NMR, ESSP, and ESMP, were enrolled. At the same time, another 10 patients with the same features were included as a control group.

The long-pulsed Nd:YAG laser has been the ideal choice for lesions off the face and for thick or deep vascular targets, although newer short-pulsed high-energy (650-microsecond) devices are showing high efficacy and safety on facial vessels as well.

One half of each axilla of six female participants was treated and the other half was monitored as a control. The treatment sites were treated with a fluence of either 21 J/cm2 or 36 J/cm2 using an Nd:YAG laser with a wavelength of 1064 nm and a pulse duration of 650-microseconds.

The laser treatment was well tolerated without any anesthesia or any form of skin cooling; the patient reported no treatment discomfort and no complications were observed.

Unlike conventional lasers and light-based devices in the field, the laser in this evaluation utilizes a unique 650-microsecond pulse duration with no skin cooling, gels or anesthetics.

A novel Nd:YAG 1064nm laser with a 650 microsecond pulse duration and a peak power of 318 joules/cm2 or 15,385 watts per pulse was used at two clinical sites over a period of 18 months.

A 650-microsecond Nd:YAG laser has recently been found to have comparable results to longer pulse duration Nd:YAG lasers without skin cooling measures.

The development of a new 1064 nm laser technology with a unique 650-microsecond pulse duration now enables virtually pain-free treatment of skin of color, with no need for skin cooling or anesthetics and no skin contact during treatment by the handpiece.

In a small study using the 650-microsecond Nd:YAG laser, one half of each axilla of six female patients was treated and the other side was monitored as a control.

A fluence of 20-25 j/cm2 was used with a pulse duration of 650-microseconds, spot size of 6mm and a repetition rate of 1 Hz.

The purpose of this study was to evaluate the treatment of onychomycosis using a novel 650-microsecond pulsed 1064-nm laser.

Laser therapy is not new to podiatry, but new technology is providing versatility and power that brings this type of therapy to a new level.

The 1064nm laser modality has been proven to be effective in clearing onychomycosis, as long as the pulse duration is in the submillisecond range and the fluence is at least 40-50 joules per square centimeter.

‍Pseudofolliculitis barbae (PFB) occurs most frequently in the beard areas of 45% to 83% of African-American men who shave.